| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |